Gray Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $734K | Buy |
4,130
+4
| +0.1% | +$711 | 0.28% | 53 |
|
|
2024
Q3 | $815K | Buy |
4,126
+146
| +4% | +$28.8K | 0.32% | 51 |
|
|
2024
Q2 | $683K | Buy |
3,980
+63
| +2% | +$10.8K | 0.29% | 54 |
|
|
2024
Q1 | $713K | Buy |
3,917
+223
| +6% | +$40.6K | 0.32% | 54 |
|
|
2023
Q4 | $573K | Sell |
3,694
-913
| -20% | -$142K | 0.28% | 60 |
|
|
2023
Q3 | $687K | Buy |
4,607
+23
| +0.5% | +$3.43K | 0.35% | 55 |
|
|
2023
Q2 | $618K | Buy |
4,584
+173
| +4% | +$23.3K | 0.31% | 61 |
|
|
2023
Q1 | $703K | Buy |
4,411
+181
| +4% | +$28.8K | 0.38% | 56 |
|
|
2022
Q4 | $684K | Sell |
4,230
-6
| -0.1% | -$970 | 0.4% | 55 |
|
|
2022
Q3 | $568K | Buy |
4,236
+40
| +1% | +$5.36K | 0.36% | 56 |
|
|
2022
Q2 | $643K | Sell |
4,196
-6
| -0.1% | -$919 | 0.39% | 50 |
|
|
2022
Q1 | $681K | Buy |
4,202
+120
| +3% | +$19.4K | 0.35% | 54 |
|
|
2021
Q4 | $553K | Buy |
4,082
+158
| +4% | +$21.4K | 0.28% | 62 |
|
|
2021
Q3 | $423K | Sell |
3,924
-462
| -11% | -$49.8K | 0.24% | 69 |
|
|
2021
Q2 | $494K | Sell |
4,386
-132
| -3% | -$14.9K | 0.28% | 64 |
|
|
2021
Q1 | $489K | Buy |
4,518
+1,414
| +46% | +$153K | 0.31% | 60 |
|
|
2020
Q4 | $334K | Sell |
3,104
-474
| -13% | -$51K | 0.23% | 72 |
|
|
2020
Q3 | $316K | Buy |
3,578
+1,128
| +46% | +$99.6K | 0.25% | 67 |
|
|
2020
Q2 | $238K | Buy |
+2,450
| New | +$238K | 0.21% | 80 |
|